$126.31
0.02% today
NYSE, Sep 23, 09:45 pm CET

Agilent Technologies Stock price

$126.33
+4.70 3.86% 1M
+4.36 3.57% 6M
-8.01 5.96% YTD
-13.46 9.63% 1Y
+1.94 1.56% 3Y
+27.71 28.10% 5Y
+91.28 260.43% 10Y
+102.25 424.54% 20Y
NYSE, Closing price Mon, Sep 22 2025
+0.01 0.01%

Key metrics

Basic
Market capitalization
$35.8b
Enterprise Value
$37.8b
Net debt
$2.0b
Cash
$1.5b
Shares outstanding
283.9m
Valuation (TTM | estimate)
P/E
30.9 | 22.2
P/S
5.4 | 5.1
EV/Sales
5.7 | 5.4
EV/FCF
31.8
P/B
5.8
Dividends
DPS
$0.99
Yield 1Y | 5Y
0.8% | 0.7%
Growth 1Y | 5Y
5.1% | 6.6%
Payout 1Y | 3Y
21.3% | 21.0%
Increased
14 Years
Financials (TTM | estimate)
Revenue
$6.6b | $7.0b
EBITDA
$1.8b | $2.1b
EBIT
$1.5b | $1.7b
Net Income
$1.2b | $1.6b
Free Cash Flow
$1.2b
Growth (TTM | estimate)
Revenue
0.6% | 8.3%
EBITDA
13.6% | 13.0%
EBIT
14.8% | 11.1%
Net Income
-6.1% | 25.3%
Free Cash Flow
-22.7%
Margin (TTM | estimate)
Gross
53.8%
EBITDA
27.5% | 29.2%
EBIT
23.3%
Net
17.6% | 22.9%
Free Cash Flow
17.9%
Financial Health
Equity Ratio
49.8%
Return on Equity
21.9%
ROCE
15.2%
ROIC
13.8%
Debt/Equity
0.6
More
EPS
$4.1
FCF per Share
$4.2
Short interest
1.2%
Employees
18k
Rev per Employee
$360.0k
Show more

Is Agilent Technologies a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,013 stocks worldwide.

Agilent Technologies Stock Analysis

Unlock Scores for Free

Analyst Opinions

26 Analysts have issued a Agilent Technologies forecast:

14x Buy
54%
12x Hold
46%

Analyst Opinions

26 Analysts have issued a Agilent Technologies forecast:

Buy
54%
Hold
46%

Financial data from Agilent Technologies

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Apr '25
+/-
%
6,628 6,628
1% 1%
100%
- Direct Costs 3,064 3,064
6% 6%
46%
3,564 3,564
6% 6%
54%
- Selling and Administrative Expenses 1,577 1,577
2% 2%
24%
- Research and Development Expense 441 441
2% 2%
7%
1,823 1,823
14% 14%
28%
- Depreciation and Amortization 277 277
7% 7%
4%
EBIT (Operating Income) EBIT 1,546 1,546
15% 15%
23%
Net Profit 1,166 1,166
6% 6%
18%

In millions USD.

Don't miss a Thing! We will send you all news about Agilent Technologies directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Agilent Technologies Stock News

Neutral
PRNewsWire
one day ago
Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities SEOUL, South Korea , Sept. 22, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, and Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and appl...
Neutral
Business Wire
6 days ago
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 24.8 cents per share of common stock. The quarterly dividend will be paid on Oct. 22, 2025, to all shareholders of record as of the close of business on Sept. 30, 2025. The timing and amounts of future dividends are subject to determination and approval by Agilent's board of direct...
Neutral
Business Wire
12 days ago
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that President and CEO Padraig McDonnell will participate in a fireside chat at this year's Bank of America Global Healthcare Conference in London. The fireside chat will be at 9:50-10:30 a.m. British Summer Time (BST) on Sept. 25 in London. A live audio webcast and replay of the presentation will be avail...
More Agilent Technologies News

Company Profile

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

Head office United States
CEO Padraig Mcdonnell
Employees 17,900
Founded 1999
Website www.agilent.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today